Literature DB >> 27616054

Adhering towards tumorigenicity: altered adhesion mechanisms in glioblastoma cancer stem cells.

Soumya M Turaga1,2, Justin D Lathia1,2,3,4.   

Abstract

Glioblastoma (GBM) is the most aggressive malignant primary brain tumor in adults with a high recurrence and mortality rate. GBM tumors contain a high degree of cellular heterogeneity, with cells exhibiting stem-like properties (cancer stem cells; CSCs) that are highly efficient at tumor initiation and are resistant to conventional therapies. CSCs interact with their tumor microenvironment by a large group of diverse cell adhesion molecules (CAMs) that participate in intercellular, intracellular and cell-extracellular matrix interactions. Despite the initial description of CAMs as tumor suppressors, recent work has highlighted specific CAMs that are essential for CSC maintenance and tumor progression. This review will highlight recent findings that provide support for a context-specific role of CAMs in CSC function and GBM progression.

Entities:  

Keywords:  cancer stem cells; cell adhesion molecules; glioblastoma

Mesh:

Substances:

Year:  2016        PMID: 27616054      PMCID: PMC6040057          DOI: 10.2217/cns-2016-0015

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  68 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.

Authors:  Michael Zorniak; Paul A Clark; John S Kuo
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

3.  Targeting cancer stem cells through L1CAM suppresses glioma growth.

Authors:  Shideng Bao; Qiulian Wu; Zhizhong Li; Sith Sathornsumetee; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

4.  Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting.

Authors:  Loïc Sauteur; Alice Krudewig; Lukas Herwig; Nikolaus Ehrenfeuchter; Anna Lenard; Markus Affolter; Heinz-Georg Belting
Journal:  Cell Rep       Date:  2014-10-16       Impact factor: 9.423

Review 5.  Adherens junctional associated protein-1: a novel 1p36 tumor suppressor candidate in gliomas (Review).

Authors:  Liang Zeng; Brian E Fee; Miriam V Rivas; James Lin; David Cory Adamson
Journal:  Int J Oncol       Date:  2014-05-08       Impact factor: 5.650

Review 6.  Brain barriers: Crosstalk between complex tight junctions and adherens junctions.

Authors:  Silvia Tietz; Britta Engelhardt
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

Review 7.  Cell Adhesion Molecules and Ubiquitination-Functions and Significance.

Authors:  Mirka Homrich; Ingo Gotthard; Hilke Wobst; Simone Diestel
Journal:  Biology (Basel)       Date:  2015-12-23

8.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

9.  Differential connexin function enhances self-renewal in glioblastoma.

Authors:  Masahiro Hitomi; Loic P Deleyrolle; Erin E Mulkearns-Hubert; Awad Jarrar; Meizhang Li; Maksim Sinyuk; Balint Otvos; Sylvain Brunet; William A Flavahan; Christopher G Hubert; Winston Goan; James S Hale; Alvaro G Alvarado; Ao Zhang; Mark Rohaus; Muna Oli; Vinata Vedam-Mai; Jeff M Fortin; Hunter S Futch; Benjamin Griffith; Qiulian Wu; Chun-Hong Xia; Xiaohua Gong; Manmeet S Ahluwalia; Jeremy N Rich; Brent A Reynolds; Justin D Lathia
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

Review 10.  Cancer stem cell contribution to glioblastoma invasiveness.

Authors:  Barbara Ortensi; Matteo Setti; Daniela Osti; Giuliana Pelicci
Journal:  Stem Cell Res Ther       Date:  2013-02-28       Impact factor: 6.832

View more
  9 in total

Review 1.  Cell adhesion in cancer: Beyond the migration of single cells.

Authors:  Michalina Janiszewska; Marina Candido Primi; Tina Izard
Journal:  J Biol Chem       Date:  2020-01-14       Impact factor: 5.157

Review 2.  Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar.

Authors:  Vashendriya V V Hira; Diana A Aderetti; Cornelis J F van Noorden
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

3.  Systems-Level Proteomics Evaluation of Microglia Response to Tumor-Supportive Anti-Inflammatory Cytokines.

Authors:  Shreya Ahuja; Iulia M Lazar
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 8.786

Review 4.  Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.

Authors:  Uchurappa Mala; Tapan Kumar Baral; Kumaravel Somasundaram
Journal:  BMC Cancer       Date:  2022-06-11       Impact factor: 4.638

5.  Functional Virtual Flow Cytometry: A Visual Analytic Approach for Characterizing Single-Cell Gene Expression Patterns.

Authors:  Zhi Han; Travis Johnson; Jie Zhang; Xuan Zhang; Kun Huang
Journal:  Biomed Res Int       Date:  2017-07-17       Impact factor: 3.411

6.  CD24 expression and stem-associated features define tumor cell heterogeneity and tumorigenic capacities in a model of carcinogenesis.

Authors:  Paola Ortiz-Montero; Win-Yan Liu-Bordes; Arturo Londoño-Vallejo; Jean-Paul Vernot
Journal:  Cancer Manag Res       Date:  2018-11-16       Impact factor: 3.989

7.  The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.

Authors:  Jin-Shu Pang; Zhe-Kun Li; Peng Lin; Xiao-Dong Wang; Gang Chen; Hai-Biao Yan; Sheng-Hua Li
Journal:  Oncol Rep       Date:  2019-02-14       Impact factor: 3.906

8.  CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas.

Authors:  Liling Liu; Yuanzhong Yang; Hao Duan; Jiahua He; Lu Sun; Wanming Hu; Jing Zeng
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

9.  Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence.

Authors:  Pengfei Wu; Wei Yang; Jianxing Ma; Jingyu Zhang; Maojun Liao; Lunshan Xu; Minhui Xu; Liang Yi
Journal:  Oncol Lett       Date:  2019-10-11       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.